Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (31-40 of 308) with videos related to

Pageof 31
Sort By:
Cancer Cytopathology|February 28, 2019
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytologyEliana Peeters, Nicolas Wentzensen, Christine Bergeron, et al.
Vaccine|April 1, 2018
Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groupsArdashel Latsuzbaia, Marc Arbyn, Steven Weyers, et al.
International Journal of Cancer|May 16, 2020
Geographic and temporal variations in the incidence of vulvar and vaginal cancersFreddie Bray, Mathieu Laversanne, Elisabete Weiderpass, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 15, 2017
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT frameworkLan Xu, Anja Oštrbenk, Mario Poljak, et al.
Plos One|April 3, 2014
Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006)Marc Arbyn, Valérie Fabri, Marleen Temmerman, et al.
Journal of Clinical Microbiology|September 14, 2018
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 FrameworkAnja Oštrbenk, Lan Xu, Marc Arbyn, et al.
Cancer|February 18, 2003
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smearsMarc Arbyn, Ulrich Schenck, Erin Ellison, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2015
Triage of HPV positive women in cervical cancer screeningNicolas Wentzensen, Mark Schiffman, Timothy Palmer, et al.
Journal of Translational Medicine|September 16, 2022
Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Jesper Bonde, Kate Cushieri, et al.
British Journal of Cancer|December 14, 2022
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screeningStefanie Costa, Bo Verberckmoes, Philip E Castle, et al.
Pageof 31

Showing results (31-40 of 308) with videos related to

Sort By:
Pageof 31
Cancer Cytopathology|February 28, 2019
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytologyEliana Peeters, Nicolas Wentzensen, Christine Bergeron, et al.
Vaccine|April 1, 2018
Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groupsArdashel Latsuzbaia, Marc Arbyn, Steven Weyers, et al.
International Journal of Cancer|May 16, 2020
Geographic and temporal variations in the incidence of vulvar and vaginal cancersFreddie Bray, Mathieu Laversanne, Elisabete Weiderpass, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 15, 2017
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT frameworkLan Xu, Anja Oštrbenk, Mario Poljak, et al.
Plos One|April 3, 2014
Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006)Marc Arbyn, Valérie Fabri, Marleen Temmerman, et al.
Journal of Clinical Microbiology|September 14, 2018
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 FrameworkAnja Oštrbenk, Lan Xu, Marc Arbyn, et al.
Cancer|February 18, 2003
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smearsMarc Arbyn, Ulrich Schenck, Erin Ellison, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2015
Triage of HPV positive women in cervical cancer screeningNicolas Wentzensen, Mark Schiffman, Timothy Palmer, et al.
Journal of Translational Medicine|September 16, 2022
Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Jesper Bonde, Kate Cushieri, et al.
British Journal of Cancer|December 14, 2022
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screeningStefanie Costa, Bo Verberckmoes, Philip E Castle, et al.
Pageof 31